© 2020 MJH Life Sciences and OncLive. All rights reserved.
April 16, 2020
Ruben A. Mesa, MD, discusses advancements made in the treatment of patients with myeloproliferative neoplasms.
February 12, 2020
Ruben A. Mesa, MD, discusses new trials and agents in the pipeline in myelofibrosis.
January 28, 2020
Ruben A. Mesa, MD, discusses the approval of fedratinib in myelofibrosis and other JAK inhibitors in the treatment pipeline.
January 16, 2020
Ruben A. Mesa, MD, director, The Mays Cancer Center, the newly named center of UT Health San Antonio MD Anderson Cancer Center, discusses the efficacy of fedratinib (Inrebic) in patients with myelofibrosis who have low platelet counts.